Literature DB >> 7541189

Phenotypic characterization of skin lesions in urticaria pigmentosa and mastocytomas.

N Haas1, K Hamann, J Grabbe, B Algermissen, B M Czarnetzki.   

Abstract

In order to identify possible cellular abnormalities in human mastocytosis, sections from 13 urticaria pigmentosa lesions and 5 mastocytomas were compared with 5 normal skin specimens using histochemical, enzyme histochemical and immunohistochemical techniques. All toluidine blue-positive mast cells also reacted with Fc epsilon RI and c-kit antibodies, almost all stained for tryptase, many for chymase and the myeloid workshop mast cell antibodies, few for Fc epsilon RII and none for the proliferation marker Ki-67. Urticaria pigmentosa lesions contained fewer epidermal Langerhans cells and a lower percentage of avidin-positive mast cells than mastocytomas and normal skin. Mastocytomas exhibited generally weaker staining for mast cell markers and mostly lacked Fc epsilon RI-bound IgE on mast cells and Langerhans cells, although the receptor was able to bind IgE in tissue sections. Most of the mast cell antibodies also reacted with other cell types. Only toluidine blue, avidin, tryptase and chymase stains were mast cell specific. Mast cells in mastocytosis thus differed only to a minor degree from normal mast cells, although distinct pathomechanisms may play a role in urticaria pigmentosa and mastocytosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541189     DOI: 10.1007/bf01105073

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  36 in total

1.  High affinity human IgE receptor (Fc epsilon RI). Analysis of functional domains of the alpha-subunit with monoclonal antibodies.

Authors:  F Riske; J Hakimi; M Mallamaci; M Griffin; B Pilson; N Tobkes; P Lin; W Danho; J Kochan; R Chizzonite
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

2.  Phenotypic evaluation of cultured human mast and basophilic cells and of normal human skin mast cells.

Authors:  K Hamann; J Grabbe; P Welker; N Haas; B Algermissen; B M Czarnetzki
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

3.  Adult mastocytosis: an immunophenotypic and flow-cytometric investigation.

Authors:  A D Ormerod; R Herriot; R J Davidson; H F Sewell
Journal:  Br J Dermatol       Date:  1990-06       Impact factor: 9.302

4.  Mast cells in rat gastrointestinal mucosa. 2. Dye-binding and metachromatic properties.

Authors:  L Enerbäck
Journal:  Acta Pathol Microbiol Scand       Date:  1966

5.  Development of human connective tissue mast cells from purified blood monocytes.

Authors:  B M Czarnetzki; C G Figdor; G Kolde; T Vroom; R Aalberse; J E de Vries
Journal:  Immunology       Date:  1984-03       Impact factor: 7.397

6.  Biochemical and histochemical evaluation of tryptase in various human tissues.

Authors:  I T Harvima; K Karkola; R J Harvima; A Naukkarinen; H Neittaanmäki; M Horsmanheimo; J E Fräki
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

7.  Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver--conditioned medium.

Authors:  K M Zsebo; J Wypych; I K McNiece; H S Lu; K A Smith; S B Karkare; R K Sachdev; V N Yuschenkoff; N C Birkett; L R Williams
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

8.  Demonstration of the high-affinity IgE receptor on human Langerhans cells in normal and diseased skin.

Authors:  J Grabbe; N Haas; K Hamann; G Kolde; J Hakimi; B M Czarnetzki
Journal:  Br J Dermatol       Date:  1993-08       Impact factor: 9.302

9.  Enzyme- and immunohistochemical localization of mast cell tryptase in psoriatic skin.

Authors:  I T Harvima; A Naukkarinen; R J Harvima; M Horsmanheimo
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

10.  The effect of recombinant mast cell growth factor on purified murine hematopoietic stem cells.

Authors:  P de Vries; K A Brasel; J R Eisenman; A R Alpert; D E Williams
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.